LSD1-IN-14 NEW
| Price | $1520 | $1980 | $2500 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-05-01 |
Product Details
| Product Name: LSD1-IN-14 | CAS No.: 2698340-11-1 |
| Supply Ability: 10g | Release date: 2025/05/01 |
Product Introduction
Bioactivity
| Name | LSD1-IN-14 |
| Description | LSD1-IN-14, a powerful and specific inhibitor of LSD1 (with an IC50 value of 0.89 μM), effectively suppresses the growth of A549 and THP-1 cells and promotes the apoptosis of tumor cells [1]. |
| In vitro | LSD1-IN-14 (compound x43) inhibits the proliferation of A549 and THP-1 cells at concentrations of 0-20 μM over 72 hours, with IC50 values of 1.62 μM and 1.21 μM, respectively [1]. At 0-3 μM, it increases H3K4me2 and H3K9me2 expression in A549 cells and induces apoptosis in 53.6% of these cells in a dose-dependent manner [1]. LSD1-IN-14 demonstrates metabolic stability in human liver microsomes with a half-life of 103.3 minutes, showing minimal inhibition of cytochrome P450 enzymes (Cl int(mic) value of 13.4 μL/min/mg at 1 mM for 60 minutes) [1]. This compound's antiproliferative effects, epigenetic modulation, and apoptosis induction make it a promising candidate for further research [1]. |
| In vivo | LSD1-IN-14, administered at dosages of 2 mg/kg intravenously (i.v.) and 10 mg/kg intragastrically (i.g.) to male Sprague-Dawley rats, exhibits an acceptable half-life and oral bioavailability. Pharmacokinetic analysis revealed: for i.v. administration, a peak concentration (C max) of 41.1 ng/mL, a half-life (T 1/2) of 1.0 hour, a steady-state volume of distribution (Vd ss) of 6.6 L/kg, a clearance rate (Cl) of 156 mL/min/kg, and an area under the curve (AUC 0-t) of 126 ng.h/mL extending to 152 ng.h/mL (AUC 0-∞). For i.g. administration, the peak concentration reached 575 ng/mL at a T max of 0.8 hours, a half-life of 2.8 hours, with an AUC 0-t of 211 ng.h/mL extending to 214 ng.h/mL (AUC 0-∞), reflecting an oral bioavailability of 11.9%. These findings suggest LSD1-IN-14 has promising pharmacokinetic properties for further development. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $118.00/1mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2025-05-16 | |
| $0.00/1KG |
VIP3Y
|
Henan Aochuang Chemical Co.,Ltd.
|
2022-09-07 | |
| $2500.00/100mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY